期刊
PLATELETS
卷 25, 期 4, 页码 252-256出版社
TAYLOR & FRANCIS INC
DOI: 10.3109/09537104.2013.809060
关键词
Cytokine; endothelial cell; fibroblast; growth factor
资金
- European Community [201681]
- European Foundation for the Study of Diabetes (EFSD)
- Associazione Italiana per la Ricerca sul Cancro (AIRC)
- Ministero dell'Universita e della Ricerca Scientifica
Platelet derivatives are commonly used in wound healing and tissue regeneration. Different procedures of platelet preparation may differentially affect growth factor release and cell growth. Preparation of platelet-rich fibrin (PRF) is accompanied by release of growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and transforming growth factor 131 (TGFIES1), and several cytokines. When compared with the standard procedure for platelet-rich plasma (PRP), PRF released 2-fold less PDGF, but >15-fold and >2-fold VEGF and TGF beta 1, respectively. Also, the release of several cytokines (IL-4, IL-6, IL-8, IL-10, IFN gamma, MIP-1 alpha, MIP-10 and TNF alpha) was significantly increased in PRF-conditioned medium (CM), compared to PRP-CM. Incubation of both human skin fibroblasts and human umbilical vein endothelial cells (HUVECs) with PRF-derived membrane (mPRF) or with PRF-CM enhanced cell proliferation by >2-fold (p<0.05). Interestingly, PRP elicited fibroblast growth at a higher extent compared to PRF. At variance, PRF effect on HUVEC growth was significantly greater than that of PRP, consistent with a higher concentration of VEGF in the PRF-CM. Thus, the procedure of PRP preparation leads to a larger release of PDGF, as a possible result of platelet degranulation, while PRF enhances the release of proangiogenic factors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据